UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques. In real time and in three dimensions, these technologies...

Moody's raises Celgene's (CELG) outlook to Positive from Stable citing the "expanding use of Revlimid" (I, II) and "pending approvals of Apremilast in psoriatic arthritis and Abraxane in pancreatic cancer" (I, II) as catalysts for "good growth momen

The ADA is the latest organization to call for an independent review into GLP-1-based therapies for type 2 diabetes to see whether they increase the risk of pancreatitis and pancreatic cancer Medscape Medical News

Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?    

Cancer is a bitch. Depending upon what organ is involved and what kind of cancer it is, it can be incredibly hard to cure. All too often, it is incurable, particularly when it involves the brain, pancreas, esophagus, or other organs. People wonder...

While the mutated KRAS oncogene is associated with many cancers, it has not yet been successfully targeted by a therapeutic agent. Scientists are trying to find another way to target the gene by blocking signals from another protein downstream.

Filed under: Investing The FDA has granted Celgene's abraxane priority review as a first-line treatment for advanced pancreatic cancer, a move that shortens the normal review period by four months. In this video, health-care analyst David...

Filed under: Investing As I noted 12 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications and better...

ORLANDO (MedPage Today) -- Patients with small, asymptomatic pancreatic neuroendocrine tumors should wait for tumor growth before considering potentially risky surgery, researchers reported here.

Using bacteria to ferry radioisotopes commonly used in cancer therapy directly into pancreatic cancer cells in mice, researchers in the US were able dramatically to reduce the number of secondary tumors that arise when the cancer spreads to other...

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify almost...

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis -- two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify...

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and...

In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal...

RICHARDSON, Texas — Susan Templer wasn't supposed to make it to 2012 or 2013.But the suburban Dallas middle school science teacher fought back against pancreatic cancer for close to two years and reached a milestone – 25 years on the...

In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal...

A mutation in a protein called menin causes a hereditary cancer syndrome called MEN1 (multiple endocrine neoplasia type 1). Individuals with MEN1 are at a substantially increased risk of developing neuroendocrine tumors, including cancer of the...

Pancreatic cancer is the fourth leading cause of death from cancer, and while family physicians in Canada only see 1 case a year, the number of cases is expected to increase as the population ages. A review in CMAJ (Canadian Medical Association...

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The experimental treatment...

Science: Pancreatic cancer is exceptionally lethal—only 4% of patients survive past 5 years—partly because of its aggressive metastasizing. Now a novel way to halt its spread has been proposed. Listeria monocytogenes is a bacterium that has...